Ucb Unsponsored Adr News, Ucb Unsponsored Adr Quote, UCBJY Quote

Ucb Unsponsored Adr (OP:UCBJY) Delayed: 145.78 -4.23 (2.82%)

Prev. Close

$150.01

Today 6M 1Y 5Y

Open

$144.58

52 Wk High

$46.25

52 Wk Low

$32.74

Day High

$146.29

Day Low

$144.34

P/E

N/A

EPS

$0.00

Volume

23,286

Friends, Peers and Foes (?): UCB:BB, UCB REGN (more...)

ALERTS | RSS

Feb 19, 2026 04:18 AM UCB (UCB:BB) (UCBJY) PT Raised to EUR330 at UBS
Feb 16, 2026 02:32 AM UCB (UCB:BB) (UCBJY) PT Raised to EUR304 at Goldman Sachs
Jan 28, 2026 09:27 AM TD Cowen on UCB SA (UCB:BB) (UCBJY): 'Impressive Bimzelx 2025 Performance To Continue In 2026'
Jan 7, 2026 02:39 AM UCB (UCB:BB) (UCBJY) PT Raised to EUR310 at Barclays
Dec 15, 2025 08:42 AM TD Cowen on UCB SA (UCB:BB) (UCBJY): 'KOL Survey Indicates Continued HS Market Growth'
Dec 15, 2025 04:38 AM UBS Reiterates Buy Rating on UCB (UCB:BB) (UCBJY)
Dec 8, 2025 07:50 AM UCB (UCB:BB) (UCBJY) PT Raised to EUR295 at Deutsche Bank
Dec 8, 2025 07:00 AM UCB's fenfluramine meets phase 3 trial goals for rare seizure disorder
Dec 8, 2025 07:00 AM UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
Dec 4, 2025 08:12 AM UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting

Entities mentioned with UCBJY

View All Entities